Rajdeep Chakraborty
Overview
Explore the profile of Rajdeep Chakraborty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chakraborty R, Zaw T, Khodlan P, Darido C, Palmisano G, Chien A, et al.
Cancer Rep (Hoboken)
. 2024 Sep;
7(9):e70019.
PMID: 39324702
Introduction: Salivary gland adenoid cystic carcinoma (ACC), mucoepidermoid carcinoma (MEC) and oral squamous cell carcinoma (OSCC) occurs within the head and neck region. So far immune check point inhibitors failed...
2.
Chakraborty R, Khodlan P, Tay A, Liu F
J Oral Biosci
. 2024 Sep;
66(4):67-73.
PMID: 39237001
Objectives: Signal transducer and activator of transcription 3 (STAT3) is one of the key proliferation mechanism-related proteins that helps in oral squamous cell carcinoma (OSCC) progression. Immune evasion by STAT3...
3.
Chakraborty R, Darido C, Chien A, Tay A, Vickery K, Hu H, et al.
Sci Rep
. 2023 Oct;
13(1):17033.
PMID: 37813936
The tumour-cell based initiation of immune evasion project evaluated the role of Gipie in adenoid cystic carcinoma (ACC) and mucoepidermoid carcinoma (A-253), from ninety-six 3D-ACC and A-253-immune co-culture models using ...
4.
Chakraborty R, Darido C, Liu F, Maselko M, Ranganathan S
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765809
Breakthrough research in the field of immune checkpoint inhibitors and the development of a human papilloma virus vaccine triggered a plethora of research in the field of cancer immunotherapy. Both...
5.
He S, Chakraborty R, Ranganathan S
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36674563
Oral squamous cell carcinoma (OSCC) is the most common head and neck malignancy, with an estimated 5-year survival rate of only 40-50%, largely due to late detection and diagnosis. Emerging...
6.
He S, Chakraborty R, Ranganathan S
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35163485
Oral cancer is the most common form of head and neck squamous cell carcinoma (HNSCC) and most frequently presents as oral squamous cell carcinoma (OSCC), which is associated with an...
7.
Chakraborty R, Hu H, Darido C, Vickery K, Ranganathan S
Int J Mol Sci
. 2021 Nov;
22(22).
PMID: 34830441
The bacterial antigen, lipopolysaccharide (LPS) and disruptions in calcium channels are independently known to influence oral cancer progression. Previously, we found that bacterial antigens, LPS and lipoteichoic acid (LTA) act...
8.
Chakraborty R, Vickery K, Darido C, Ranganathan S, Hu H
Int J Mol Sci
. 2021 Aug;
22(16).
PMID: 34445392
Oral cancer is a major global health problem with high incidence and low survival rates. The oral cavity contains biofilms as dental plaques that harbour both Gram-negative and Gram-positive bacterial...